An Effective Anti-Cancer Combination Therapy, with Substantially Reduced Side Effects
Tech ID: 20801 / UC Case 2010-482-0
An image guided effective anti-cancer therapy, with greatly reduced side effects, using liposomal copper doxorubicin
Researchers at the University of California, Davis have developed an effective local therapeutic strategy with substantially reduced side effects using a combined treatment with increased and stable loading of doxorubicin (Dox) using a complex of Dox and copper (II). Cu-liposomes were loaded with Dox up to a maximum concentration of 0.6mg-drug/mg-lipid with 100% loading. UC Davis researchers have studied the efficacy of Cu-Dox liposomes and optimized the treatment strategy using the highly invasive and metastatic Met-1 tumor, a syngeneic model of human breast carcinoma. All animals receiving the combined therapy survived throughout the 28 day course treatment and did not show any side effects throughout the 28 day of treatment. A significant tumor regression was accomplished on combining Cu-Dox liposomes with another drug and tumor insonation.
- Reduced side effects
- Enhanced anti-tumor activity when combined with entire tumor insonation
|Patent Cooperation Treaty||Reference for National Filings||WO 11/109334 A3||09/09/2011||2010-482|
- Ferrara, Katherine W.
- Kheirolomoom, Azadeh
Anti-cancer combination therapy, Image guided cancer therapy, Liposomal Copper Doxorubicin